Results 251 to 260 of about 31,062 (287)

Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR‐Reduced

European Journal of Heart Failure, EarlyView.
Empagliflozin effects and heart failure outcomes in patients with heart failure with reduced ejection fraction and atrial fibrillation or sinus rhythm. AF, atrial fibrillation; CV, cardiovascular; eGFR, estimated glomerular filtration rate; HHF, hospitalization for heart failure; KCCQ, Kansas City Cardiomyopathy Questionnaire; SE, standard error ...
Michael Böhm, Javed Butler, Amr Abdin, Gerasimos Filippatos, João Pedro Ferreira, Stuart J. Pocock, Martina Brueckmann, Anne Pernille Ofstad, Elke Schueler, Christoph Wanner, Faiez Zannad, Stefan D. Anker, Milton Packer, on behalf of the EMPEROR‐Reduced Trial Committees and Investigators   +13 more
wiley   +1 more source

Machine learning enhanced acute heart failure phenotype prediction using natural language processing and random forest. [PDF]

Front Artif Intell
Chang PH, Liao FC, Wu YC, Sun FJ, Liu YY, Yeh HI, Hung CL, Wu KP.   +7 more
europepmc   +1 more source

Low‐dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation – the RATE‐AF randomized trial

European Journal of Heart Failure, EarlyView.
Summary of the change in left ventricular systolic and diastolic parameters from baseline to 12 months in patients with permanent atrial fibrillation (AF) and a left ventricular ejection fraction (LVEF) ≥50%. P‐values indicate the significance of the adjusted mean difference of the parameters at 12 months between the beta‐blocker and digoxin arm. E/e′,
Karina V. Bunting, Asgher Champsi, Simrat K. Gill, Khalil Saadeh, A. John Camm, Mary Stanbury, Sandra Haynes, Jonathon N. Townend, Richard P. Steeds, Dipak Kotecha, on behalf of the RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group   +10 more
wiley   +1 more source

Cardiac Rehabilitation in the Era of CRT and ARNI: A Missing Link in Heart Failure with Reduced Ejection Fraction Care. [PDF]

J Clin Med
Pătru O, Luca S, Cozma D, Văcărescu C, Crișan S, Valcovici MD, Vîrtosu M, Zus AS, Luca CT, Drăgan SR.   +9 more
europepmc   +1 more source

Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF‐CAP) in China

European Journal of Heart Failure, EarlyView.
Nationwide implementation of heart failure therapies in China. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; CV, cardiovascular; GDMT, guideline‐directed medical therapy; HF, heart failure; HF‐CAP, National Heart Failure Center Accreditation ...
Jingmin Zhou, Xuejuan Jin, Yamei Xu, Zhonglei Xie, Xiaotong Cui, Yanyan Wang, Hua Wang, Xinli Li, Yugang Dong, Yuhua Liao, Weimin Li, Alexandre Mebazaa, Jiefu Yang, Junbo Ge, on behalf of the Heart Failure Center Accreditation Program Investigators   +14 more
wiley   +1 more source

Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study. [PDF]

Lancet Reg Health Eur
Svanström H, Mkoma GF, Hviid A, Pasternak B.   +3 more
europepmc   +1 more source

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

European Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak, Titus Kuehne, Pauline Fahjen, Nina Jovanovic, Ulrike Löber, Gabriele G. Schiattarella, Nicola Wilck, Holger Gerhardt, Dominik N. Müller, Frank Edelmann, Philipp Mertins, Roland Eils, Michael Gotthardt, Sofia K. Forslund, Benjamin Wild, Marcus Kelm   +15 more
wiley   +1 more source

Clinical and Echocardiographic Profile of Patients With Heart Failure With Reduced Ejection Fraction: A Retrospective Outcome Analysis. [PDF]

Cureus
Irfan S, Padmakaran V, Prasanth R, Nazar S, Srinivas S, Tv AK, Bhandary VS, Patel PV, Baldota R, Puthenveedu Soman A, Vattapothy BA.   +10 more
europepmc   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

European Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis, Marianna Adamo, Volker Rudolph, Nicole Karam, Ralph Stephan von Bardeleben, Stefan D. Anker, Victoria Delgado, Jörg Hausleiter, Hannah Kempton, Marco Metra, Michael Böhm, Stephan Baldus   +11 more
wiley   +1 more source

Diagnostic and prognostic value of circulating biomarkers in heart failure. [PDF]

Front Cardiovasc Med
Kovenskiy A, Mukhatayev Z, Sailybayeva A, Bekbossynova M, Kushugulova A.   +4 more
europepmc   +1 more source